# WHO recommended dolutegravir as preferred first-line HIV treatment for all populations

Date: 2019

_No public text on this fact yet._

## Drivers

- HIV/AIDS global response: https://factrail.ai/drivers/hiv-aids-response

## Sources

_Sources are listed on the canonical page._

## Methodology

https://factrail.ai/methodology

Canonical: https://factrail.ai/facts/who-dolutegravir-preferred-first-line-2019